1072 related articles for article (PubMed ID: 31681276)
1. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
2. Effective Predictor of Colorectal Cancer Survival Based on Exclusive Expression Pattern Among Different Immune Cell Infiltration.
Xu X; Ma J; Yu G; Qiu Q; Zhang W; Cao F
J Histochem Cytochem; 2021 Apr; 69(4):271-286. PubMed ID: 33550891
[TBL] [Abstract][Full Text] [Related]
3. The correlation between infiltration of FoxP3
Ren Y; Chen Z; Sun J; Cai Y; Chen Z; Chen X; Wu W
Cent Eur J Immunol; 2022; 47(1):1-7. PubMed ID: 35600158
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
Kikuchi T; Mimura K; Ashizawa M; Okayama H; Endo E; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Shimada K; Yoshimura K; Tsunoda T; Kono K
Cancer Immunol Immunother; 2020 Jan; 69(1):23-32. PubMed ID: 31768581
[TBL] [Abstract][Full Text] [Related]
5. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.
Kitano Y; Okabe H; Yamashita YI; Nakagawa S; Saito Y; Umezaki N; Tsukamoto M; Yamao T; Yamamura K; Arima K; Kaida T; Miyata T; Mima K; Imai K; Hashimoto D; Komohara Y; Chikamoto A; Ishiko T; Baba H
Br J Cancer; 2018 Jan; 118(2):171-180. PubMed ID: 29123259
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
8. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
9. Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types.
Dakal TC; George N; Xu C; Suravajhala P; Kumar A
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730579
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.
Bauer K; Michel S; Reuschenbach M; Nelius N; von Knebel Doeberitz M; Kloor M
Fam Cancer; 2011 Sep; 10(3):557-65. PubMed ID: 21598004
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Infiltration of CD163+ TAMs, FoxP3+ Tregs, or CD66b+ TANs and Cell Differentiation in Colorectal Cancer Tissues.
Wang X; Bai Y; Zhou Z; Ye B; Chen Z; Chen X; Wu W
Turk J Gastroenterol; 2023 Jul; 34(7):747-752. PubMed ID: 37232465
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
Guo L; Wang C; Qiu X; Pu X; Chang P
Front Immunol; 2020; 11():1052. PubMed ID: 32547556
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
Yu S; Wang Y; Hou J; Li W; Wang X; Xiang L; Tan D; Wang W; Jiang L; Claret FX; Jiao M; Guo H
PLoS One; 2020; 15(4):e0231003. PubMed ID: 32240238
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
16. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
17. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.
Fakih M; Ouyang C; Wang C; Tu TY; Gozo MC; Cho M; Sy M; Longmate JA; Lee PP
J Clin Invest; 2019 Oct; 129(10):4464-4476. PubMed ID: 31524634
[TBL] [Abstract][Full Text] [Related]
18. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 is a double-edged sword in colorectal cancer: the prognostic value of PD-L1 depends on the cell type expressing PD-L1.
Ho HL; Chou TY; Yang SH; Jiang JK; Chen WS; Chao Y; Teng HW
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1785-1794. PubMed ID: 31129768
[TBL] [Abstract][Full Text] [Related]
20. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
